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The metabolic effects of carbohydrate supplementation in mice have
not been extensively studied. In rats, glucose- and fructose-rich diets
induce hypertriacylglycerolemia. In the present study, we compared
the metabolic responses to two monosaccharide supplementations in
two murine models. Adult male Wistar rats (N = 80) and C57BL/6
mice (N = 60), after 3 weeks on a standardized diet, were submitted to
dietary supplementation by gavage with glucose (G) or fructose (F)
solutions (500 g/L), 8 g/kg body weight for 21 days. Glycemia was
significantly higher in rats after fructose treatment (F: 7.9 vs 9.3 mM)
and in mice (G: 6.5 vs 10 and F: 6.6 vs 8.9 mM) after both carbohydrate
treatments. Triacylglycerolemia increased significantly 1.5 times in
rats after G or F supplementation. Total cholesterol did not change
with G treatment in rats, but did decrease after F supplementation (1.5
vs 1.4 mM, P < 0.05). Both supplementations in rats induced insulin
resistance, as suggested by the higher Homeostasis Model Assess-
ment Index. In contrast, mice showed significant decreases in triacyl-
glycerol (G: 1.8 vs 1.4 and F: 1.9 vs 1.4 mM, P < 0.01) and total
cholesterol levels (G and F: 2.7 vs 2.5 mM, P < 0.05) after both
monosaccharide supplementations. Wistar rats and C57BL/6 mice,
although belonging to the same family (Muridae), presented opposite
responses to glucose and fructose supplementation regarding serum
triacylglycerol, free fatty acids, and insulin levels after monosaccha-
ride treatment. Thus, while Wistar rats developed features of
plurimetabolic syndrome, C57BL/6 mice presented changes in serum
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Introduction
In the 1950’s, the energy from dietary fat
was replaced by carbohydrates (1,2) in an
attempt to reduce serum cholesterol concen-
tration. However, high carbohydrate diets,
particularly diets containing sucrose and fruc-
tose, increase serum triacylglycerol (TG)
and decrease high-density lipoprotein (HDL)
cholesterol, contributing to an increased risk
of cardiovascular disease (3-6).
Before industrialization, starch was the
principal carbohydrate in regular diets, while
fructose was a minor diet component. Dur-
ing the past two decades, fructose intake has
increased steadily due to its use as a sweet-
ener in pharmaceutical and food products
such as carbonated beverages, canned fruits,
jams, jellies, and dairy products.
Several studies have shown that high
fructose or glucose consumption by humans
(5-8) and laboratory animals (7,9-17) can
affect carbohydrate and lipid metabolism.
Rats fed a high-sucrose and -fructose diet
presented metabolic changes observed in
the human X syndrome, a disorder charac-
terized by insulin resistance, hypertension
and dyslipidemia (10,18-22). However, in
mice, the effect of a high-carbohydrate diet
on lipid and carbohydrate metabolism has
not been studied extensively. Surwit et al.
(23) showed that C57BL/6J mice carry a
genetic predisposition to the development of
non-insulin-dependent diabetes mellitus and
obesity, hyperglycemia, hyperinsulinemia,
insulin resistance, and hypertension when
fed a high-fat, high-simple carbohydrate diet.
They described different effects of dietary
fat and sucrose on the development of obe-
sity and diabetes in C57BL/6J and A/J mice.
For instance, plasma glucose levels were not
affected by dietary sucrose in A/J and C57BL/
6J mice. However, different types of diet did
not affect the plasma insulin levels in the A/
J mice, whereas in C57BL/6J mice a low-
sugar diet resulted in higher levels of insulin
when compared to A/J mice on a low-fat diet
with either low or high sugar content (15,16).
Shafrir et al. (24) showed a significant in-
crease in triacylglycerol levels in spiny mice
(Acomys cahirinus) after long-term high su-
crose consumption. Also, Ostos et al. (25)
showed that long-term fructose consump-
tion had a strong adverse effect in hypertri-
acylglycerolemic atherosclerosis-protected
transgenic mice that over-expressed the hu-
man apolipoprotein AI-CIII-AIV gene clus-
ter.
Since rats and mice are frequently used
as experimental models for several meta-
bolic disturbances and for the study of diet
manipulations, the objective of the present
study was to compare the effects of two
simple carbohydrate diet supplementations
(fructose or glucose) on the glucose and
lipid profile of two members of the Muridae
family: Wistar rats (Rattus norvegicus) and
C57BL/6 mice (Mus musculus).
Material and Methods
Animals and experimental design
The experimental protocol was approved
by the Ethics Committee for Animal Experi-
mentation (Biology Institute, State Univer-
sity of Campinas, Campinas, SP, Brazil).
Forty male Wistar rats and 30 C57BL/6 male
mice obtained from the Multidisciplinary
Center of Biological Investigation (CEMIB),
State University of Campinas (UNICAMP),
3-5 weeks old, weighing on average 240 ±
32 and 21 ± 2.5 g, respectively, were used in
this study. Wistar rats were housed (4 ani-
mals per cage) in a temperature-controlled
room (22ºC) with 12-h light-dark cycles and
received for 3 weeks a standard rodent diet
(Nuvital, Curitiba, PR, Brazil) and water ad
libitum. After 12 h of fasting, tail blood was
obtained at 7 am.
The basal biochemical serum parameters
considered were: cholesterol, HDL choles-
terol, TG, free fatty acids, glucose, and insu-
lin concentrations. The rats received fruc-
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tose or glucose solutions (500 g/L) at 8 g/kg
body weight/day by gavage, twice a day at 8
am and 2 pm for 21 days. Free water and
chow diet (composition: 220 g protein, 45 g
fat, 408 g carbohydrate, 122 g mineral mix,
80 g fiber, 125 g humidity per 1000 g of diet)
consumptions as well as body weight were
measured weekly. At the end of the 21-day
period, 12-h fasted rats were lightly anesthe-
tized with ether for tail blood collection to
measure the same biochemical parameters.
C57BL/6 mice were housed in cages for 6
animals kept under the same conditions and
submitted to the same protocol as described
above.
At the end of the experiment, all animals
were anesthetized intraperitoneally with keta-
mine (50 mg/kg, Ketalar, Parke-Davis, Gua-
rulhos, SP, Brazil) and xylazine (16 mg/kg,
Rompum, Bayer S.A., São Paulo, SP, Bra-
zil) and blood was obtained through the
retro-orbital plexus. Rat and mouse serum
pools (3 animals in each condition) were
submitted to fast protein liquid chromatog-
raphy (FPLC), as described in Methods, to
determine the triacylglycerol and choles-
terol distribution in plasma lipoproteins.
Methods
Serum total cholesterol, HDL cholesterol,
TG, and glucose were determined by enzy-
matic colorimetric methods using an auto-
mated Hitachi 917 system (Boehringer,
Mannheim, Germany). Free fatty acids (FFA)
were measured with an enzymatic colori-
metric kit (Wako Chemicals, Richmond, VA,
USA) and insulin was determined by ELISA
(Ultra Sensitive Rat Insulin ELISA, Crystal
Chem. Inc., Dowers Grove, IL, USA). Inter-
assay coefficients of variation were 1.4, 5.8,
1.4, 1.5, 2.4, and 3.8%, respectively, for
glucose, insulin, cholesterol, TG, HDL cho-
lesterol, and FFA determinations. Lipopro-
tein was isolated by FPLC (Pharmacia, Upp-
sala, Sweden) using an HR 10/30 Superose 6
column (Amersham Pharmacia Biotech,
Uppsala, Sweden) with Tris-buffered saline,
pH 7.4, in a 0.5 mL/min flow rate (26). The
cholesterol and TG present in the fractions
were determined with an automatic Cobas
system (Roche, Basel, Switzerland). Insulin
resistance was estimated by the homeostasis
model assessment (HOMA) index as fol-
lows (27): fasting insulin (mU/L) x fasting
glucose (mmol/L)/22.5.
Statistical analysis
The paired t-test and ANOVA followed
by the post hoc Tukey test were used to
compare the effects of carbohydrates (be-
fore and after) and the effects of the monosac-
charides fructose and glucose administered
to rats and mice, respectively. Some vari-
ables were log transformed due to the ab-
sence of normal distributions. The Pearson
coefficient was used to test the correlation of
diet, water consumption, and weight gain
(areas under the weight vs time curves, AUC)
with the percent variation of the biochemical
parameters. Comparison between animal
genera (Rattus x Mus) was made by the
Student t-test (28). All comparisons where
made using SAS System for Windows (Sta-
tistical Analyses System Institute Inc., 1999-
2000, Cary, NC, USA), version 8.01. Statis-
tical significance was set at P < 0.05.
Results
Body weight, food and water consumption of
Wistar rats and C57BL/6 mice
In rats, the total AUCs for body weight,
food and water consumption were signifi-
cantly larger during glucose than during fruc-
tose supplementation (Figure 1A). The in-
cremental AUCs (IAUC) of body weight
were similar in the two dietary programs
(Figure 1B: 40 ± 3.3 and 48 ± 4.3 g for 3
weeks for glucose- and fructose-treated rats,
respectively). However, the IAUC (Figure
1B) of food intake was significantly smaller
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In mice, the AUC and IAUC of body
weight and food intake were similar for the
two dietary supplements. Contrary to the
rats’ response, water consumption was sig-
nificantly larger in fructose- than in glucose-
supplemented mice (Figure 1C and D).
Biochemical serum parameters of Wistar
rats before and after carbohydrate
supplementation
A comparison of the effects of glucose
and fructose supplementation on the fasting
lipid profile and on insulin and glucose con-
centrations in Wistar rats is presented in
Table 1. Glycemia and cholesterolemia were
significantly higher and lower, respectively,
when fructose was administered. An increase
in insulin levels was observed in glucose-
(26%) and fructose-supplemented (54%) rats.
However, no statistical differences was de-
monstrable, probably due to the small sam-
ple number available for this assay (N = 5
and 7 animals in each group, respectively).
Also, the homeostasis model assessment-
insulin resistance (HOMAIR) parameter was
increased after glucose and fructose supple-
mentation (9.5 ± 3.4 vs 12.7 ± 5.3, and 7.8 ±
2.2 vs 8.9 ± 1.4, before vs after glucose and
fructose supplementation, respectively). No
statistical differences were demonstrable.
The triacylglycerolemia was significant-
ly increased 1.5-fold after supplementation
with both carbohydrates (glucose or fruc-
tose) and this effect was also demonstrated
on very low-density lipoprotein (VLDL)-
TG content (Figure 2, panels A and B, re-
spectively, for the glucose and fructose sup-
plementation). In contrast, FFA levels did
not change after supplementation with glu-
cose or fructose (Table 1).
Serum total cholesterol was not modified
by glucose supplementation. However, cho-
lesterol distribution in plasma lipoproteins
was significantly altered: HDL cholesterol
increased by 13% and non-HDL cholesterol
decreased by 15%. Total serum cholesterol
Figure 1. Total and incremental areas under the curves (AUC and IAUC) of body weight,
diet and water consumption for Wistar rats (N = 40, panels A and B) and C57BL/6 mice (N =
30, panels C and D) treated with 8 g/kg body weight of glucose/day or fructose/day for 21
days. Data are reported as means ± SEM. *P < 0.01 compared to fructose (one-way
ANOVA).
Table 1. Fasting serum biochemical parameters of Wistar rats before and after
supplementation with glucose or fructose for 21 days.
Glucose Fructose
Before After Before After
Glucose (mM) 8.9 ± 0.2 9.3 ± 0.2 7.9 ± 0.23 9.3 ± 0.1*
Insulin (mU/L) 26.9 ± 12.9 34.1 ± 12.3 23.9 ± 6.7 37.1 ± 15.9
Cholesterol (mM) 1.6 ± 0.03 1.6 ± 0.03 1.5 ± 0.03 1.4 ± 0.04*
Triacylglycerol (mM) 0.9 ± 0.06 1.5 ± 0.08* 1.4 ± 0.1 2.1 ± 0.1*
HDL cholesterol (mM) 0.8 ± 0.06 0.9 ± 0.04* 1.1 ± 0.02 1.0 ± 0.03*
nHDL cholesterol (mM) 0.8 ± 0.06 0.7 ± 0.05* 0.4 ± 0.02 0.4 ± 0.03
Free fatty acids (mEq/L) 0.6 ± 0.06 0.5 ± 0.05 0.4 ± 0.03 0.4 ± 0.01
Rats received 8 g/kg body weight per day of glucose and fructose. Data are reported
as means ± SEM. N = 40 for each treatment except for insulin data (glucose, N = 5;
fructose, N = 7). HDL cholesterol = cholesterol in high-density lipoproteins; nHDL
cholesterol = cholesterol in non-HDL particles.
*P < 0.05 before vs after treatment (ANOVA).
for the fructose group than for the glucose
group. This suggests that food efficiency
(food consumption/weight gain) was higher
when fructose was used as a dietary supple-
ment compared to glucose. Interestingly, glu-
cose-supplemented rats drank approximately
twice as much water as fructose-supple-
mented rats (P < 0.05, Tukey test).
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level decreased by 7% after fructose supple-
mentation in rats (P < 0.05). The percentage
of cholesterol content in LDL particles also
decreased (Figure 2, panels C and D) after
both glucose and fructose supplementation,
and HDL cholesterol decreased by 10% in
rats treated with fructose.
When comparing the effects of glucose
and fructose (expressed as the percentage of
basal levels) in promoting serum biochemi-
cal variations, the fructose supplementation
promoted a higher increase of fasting glyce-
mia (16.7 vs 4.7%, P = 0.004), a milder
increase in triacylglycerolemia (41 vs 62%,
P = 0.08) and a significant decrease in cho-
lesterolemia (-6.7 vs 0%, P = 0.01, respec-
tively) when compared with glucose supple-
mentation.
Biochemical serum parameters of C57BL/6
mice before and after carbohydrate
supplementation
A comparison of the effects of carbohy-
drate supplementation on the fasting lipid
profile and on insulin and glucose concen-
trations in C57BL/6 mice is presented in
Table 2.
Mice presented a significant increase in
fasting glycemia, 45% on average after both
carbohydrate diet supplementations. The glu-
cose treatment was responsible for a signifi-
cant decrease in insulin levels (33%), but the
HOMAIR was not modified by either carbo-
hydrate treatment (1.8 ± 0.5 vs 1.8 ± 0.5, and
1.2 ± 0.3 vs 1.3 ± 0.2, before vs after glucose
and fructose treatments, respectively).
The lipid profile was significantly al-
tered by glucose and fructose supplementa-
tions, with decreases in cholesterol, TG, non-
HDL cholesterol and decreases in FFA lev-
els only in fructose-treated mice (Table 2).
The decrease in triacylglycerolemia
(24%) was also observed in the TG content
of VLDL particles (Figure 3, panels A and
B). The decrease in cholesterol in non-HDL
particles was caused by a decrease mainly in
Figure 2. Distribution of triacylglycerol (A and B) and cholesterol (C and D) in Wistar rat
serum lipoproteins isolated by FPLC before and after dietary supplementation with 8 g/kg
body weight of glucose/day (A, C) or fructose/day (B, D) for 21 days. The data were
obtained by FPLC analyses of pooled serum samples from 3 rats in each condition. The
percentage of triacylglycerol and cholesterol in lipoprotein classes was calculated as the
areas under the peaks of each lipoprotein class using the sum of all values of triacylglycerol
or cholesterol determined in each fraction as 100% (total area under the three peaks of very
low- (VLDL), low- (LDL) and high-density lipoprotein (HDL).
Table 2. Fasting serum biochemical parameters of C57BL/6 mice before and after
supplementation with glucose or fructose for 21 days.
Glucose Fructose
Before After Before After
Glucose (mM) 6.5 ± 0.2 10.0 ± 0.5* 6.6 ± 0.2 8.9 ± 0.47*
Insulin (mU/L) 6.7 ± 2.2 4.4 ± 0.9* 5.4 ± 1.0 3.5 ± 0.6
Cholesterol (mM) 2.7 ± 0.08 2.5 ± 0.03* 2.7 ± 0.05 2.5 ± 0.03*
Triacylglycerol (mM) 1.8 ± 0.11 1.4 ± 0.05* 1.9 ± 0.1 1.4 ± 0.05*
HDL cholesterol (mM) 2.0 ± 0.03 1.9 ± 0.04 2.1 ± 0.03 1.9 ± 0.04*
nHDL cholesterol (mM) 0.7 ± 0.08 0.6 ± 0.04* 0.6 ± 0.04 0.5 ± 0.03*
Free fatty acids (mEq/L) 2.4 ± 0.3 1.8 ± 0.1 2.2 ± 0.2 1.9 ± 0.2*
Mice received 8 g/kg body weight per day of glucose and fructose. Data are reported
as means ± SEM. N = 30 for each treatment except for insulin data (N = 9 for each
treatment). HDL cholesterol = cholesterol in high density lipoproteins; nHDL choles-
terol = cholesterol in non-HDL particles.
*P < 0.05 before vs after treatment (ANOVA).
VLDL cholesterol content (Figure 3, panels
C and D).
Comparison between the effects of glu-
cose and fructose, as percentage of basal
levels, shows that fructose supplementation
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was more potent for lowering free fatty acid
concentrations than glucose treatment in
C57BL/6 mice (P < 0.01).
Correlation analyses
A significant positive correlation was
found between the variation of glycemia and
body weight gain (AUC) in rats treated with
glucose and fructose (r = 0.36, P = 0.014).
The variation in serum HDL cholesterol (r =
-0.42, P = 0.0033) and TG (r = -0.49, P =
0.0006) correlated negatively with body
weight gain (AUC) in glucose-treated but
not in fructose-treated rats.
Comparison of glucose and fructose dietary
supplementation in rats and mice
Wistar rats and C57BL/6 mice presented
different metabolic responses when submit-
ted to a relatively short period of dietary
supplementation with glucose and fructose.
They responded in opposite ways in terms of
variations in triacylglycerolemia, FFA and
insulinemia after both monosaccharide treat-
ments. In addition, C57BL/6 mice presented
a greater decrease in cholesterol, HDL cho-
lesterol and non-HDL cholesterol concen-
trations (P = 0.04; P = 0.01; P = 0.03, respec-
tively) when compared with glucose- and
fructose-supplemented Wistar rats.
Discussion
Genetic and environmental factors are
considered to be responsible for metabolic
disturbances such as plurimetabolic syn-
drome, diabetes mellitus, dyslipidemia, and
obesity. Among environmental factors, the
refined carbohydrates, extensively used in
industrialized countries, are among the most
important causes of these disturbances.
Several investigators have demonstrated
that high-glucose or -fructose diets are asso-
ciated with the development of insulin resis-
tance, and increased serum TG and insulin
levels (1,2,4,6,13,29-34).
The present results show that carbohy-
drate supplementations were responsible for
the increase in fasting glycemia in both rats
and mice, although this increase was not
statistically significant in glucose-supple-
mented rats. In rats, the increases in insulin
levels after carbohydrate treatments were 26
and 54%, respectively, for glucose- and fruc-
tose-treated rats, in agreement with the re-
sults of Huang et al. (34) and Kelley et al.
(13). Higher insulin, glucose and TG levels
in the glucose- and fructose-treated rats indi-
cate that the animals probably developed
insulin resistance. Surprisingly, the carbo-
hydrate-supplemented C57BL/6 mice
showed significant reductions in fasting in-
sulin levels. Similar results were obtained by
Ostos et al. (25) with fructose-supplemented
control C57BL/6 mice. Differently, Rebuffe-
Scrive et al. (17) showed hyperglycemia,
hyperinsulinemia, hypercholesterolemia, and
increased visceral fat depot in C57BL/6J
Figure 3. Distribution of triacylglycerol (A and B) and cholesterol (C and D) in C57BL/6
mouse serum lipoproteins isolated by FPLC before and after dietary supplementation with
glucose (A and C) or fructose (B and D) for 21 days. The data were obtained by FPLC
analyses of pooled serum samples from 3 mice in each condition. The percentage of
triacylglycerol and cholesterol in lipoprotein classes was calculated as the areas under the
peaks of each lipoprotein class using the sum of all values of triacylglycerol or cholesterol
determined in each fraction as 100% (total area under the three peaks of very low- (VLDL),
low- (LDL) and high-density lipoprotein (HDL).
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mice when compared with the control A/J
mouse strain after 5 months of high-fat, high-
simple (primarily disaccharides) carbohy-
drate diets. Thus, the differences between
Wistar rats and C57BL/6 mice described
here may be related to the specific mouse
strain rather than to the animal genus.
High-carbohydrate diets are recom-
mended for humans to lower the risk of
coronary heart diseases because they de-
crease LDL cholesterol concentrations (35-
37). In the present study, we found signifi-
cant decreases in total cholesterol in both
rodent genera (Wistar rats and C57BL/6
mice) after both glucose and fructose sup-
plementation. Although glucose-treated rats
did not show a significant decrease in total
cholesterol, they presented lower non-HDL
cholesterol levels.
The increase in triacylglycerolemia found
in glucose-supplemented rats was more pro-
nounced than that produced by fructose (62
vs 41% for glucose and fructose, respective-
ly), although the absorbed fructose is prefer-
ably taken up by the liver independently of
the rate-limiting glycolytic enzymes (8). The
concomitant increases in the TG and choles-
terol content of VLDL in carbohydrate-
supplemented rats suggest an increased he-
patic secretion rate of VLDL particles and
impaired plasma VLDL clearance, which
are frequently observed in diabetes and insu-
lin resistance states.
In C57BL/6 mice, on the other hand, the
significant decrease of approximately 20%
in triacylglycerolemia, observed after sup-
plementation with both monosaccharides,
was probably due to a decrease in hepatic
VLDL-TG secretion. Our results differ from
those reported by Shafrir et al. (24) in a study
on spiny mice treated with a sucrose-rich
diet for a long time (7 months). These inves-
tigators found a significant increase in TG
when compared to controls treated with a
commercial diet. On the other hand, Ostos et
al. (25) did not find any statistical difference
in TG concentration in C57BL/6 mice supple-
mented with fructose for 9 months. How-
ever, transgenic C57BL/6 mice over-express-
ing the human gene cluster AI-CIII-AIV,
that present basal hypertriacylglycerolemia,
responded with an additional increase in TG
levels when submitted to fructose supple-
mentation.
Menahan and Sobocinski (38) described
a differential response to regular feeding in
Sprague-Dawley rats and Swiss mice. In the
fed state, Swiss mice presented higher gly-
cemia than Sprague-Dawley rats, but this
difference disappeared after 48 h of fasting.
Serum concentrations of TG and insulin were
similar in these rats and mice in the fed as
well as in the fasting state.
Wistar rats and C57BL/6 mice belonging
to the same Muridae family are regularly
used as experimental models for metabolic
studies in an indistinct way, but they are very
different metabolically. This study presents
for the first time in the literature strikingly
different responses between these two gen-
era after challenge with both carbohydrate
oral supplementations for 21 days: Wistar
rats acquired insulin resistance and hyperin-
sulinemia whereas C57BL/6 mice presented
carbohydrate intolerance with low-plasma
insulin levels; rats increased triglycerides
and had no changes in FFA and C57BL/6
mice reduced both triglycerides and FFA
(significantly only with fructose treatment).
Glucose supplementation caused an el-
evation in HDL cholesterol in Wistar rats but
no changes were observed in C57BL/6 mice,
and, in contrast, fructose significantly re-
duced HDL cholesterol in both rats and mice.
Glucose, but not fructose, supplementation
reduced non-HDL cholesterol in Wistar rats,
while in C57BL/6 mice both carbohydrates
reduced non-HDL cholesterol.
Since the mainly used rodent reference
for metabolic studies in the literature is the
Wistar rat, this study points to important
differences in C57BL/6 mice that should be
highlighted and emphasized in the scientific
community.
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The new contribution of this research is
that similar metabolic responses to humans,
after sub-acute carbohydrate intake, were
detected only in Wistar rats and were mainly
the features of the metabolic syndrome. Sur-
prisingly, the response of C57BL/6 mice
under the same treatment conditions pointed
to an anti-atherogenic lipid plasma profile.
Future studies of Murine models should aim
at understanding the mechanisms of these
striking metabolic differences and of the
suggestive diverse atherogenic patterns.
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